SAFETY AND PK OF SUBCUTANEOUS GS-6207, A NOVEL HIV-1 CAPSID
INHIBITOR
Reported by Jules Levin
CRI 2019 March 4-7 Seattle
Jennifer E Sager, Rebecca Begley, Martin Rhee, Steve K. West, John Ling,
Scott D. Schroeder, Winston C. Tse, Anita Mathias
Gilead Sciences, Inc, Foster City, CA, USA
